-
-
-
-
-
-
-
Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results
-
-
-
-
-
-
-
Alpine Immune Sciences (ALPN) Reports Q4, Provides Corporate Update
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating, $17 Price Target on Alpine Immune Sciences (ALPN) Ahead of ALPN-303 First-in-Human Data
-
-
-
-
-
-
-
Alpine Immune Sciences Provides Corporate Update and Reports First Quarter 2021 Financial Results
-
-
-
-
-
-
-
Alpine Immune Sciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Alpine Immune Sciences Provides Corporate Update and Reports First Quarter 2019 Financial Results
-
-
-
-
-
-
-
Superior Uniform Group (SGC) Tops Q2 EPS by 3c
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

